Immunoglobulin production is impaired in 4,5 Two explanations have been considered so far for this Ig down-regulation: "crippling" mutations within the transcription control regions and/or in the coding sequence 6 ; and the absence or diminished production of critical transcription factors. [7][8][9] Crippling mutations in the Ig coding regions can hardly be considered to be a main cause of Ig down-regulation in HRS cells because the vast majority of cHL cases (75%) harbor functionally rearranged Ig genes without mutations. 4 Likewise, mutations in the Ig regulatory elements are also not responsible for the absence of Ig transcription because they were found in only one cHL-derived cell line, L1236 (mutation in the first position of the octamer motif of the variable region of the Ig heavy chain gene [V H ] promoter), but not in isolated primary HRS cells, except in one cHL case. 7,10,11 In contrast, the absence or substantial down-regulation of B-cellspecific transcription factors, such as octamer-binding transcription factor (Oct2) and B-cell Oct binding protein/Oct-binding factor (BOB.1/ OBF.1) 7-9 as well as the Ets family member PU.1, [12][13][14] was observed in all cHL cell lines as well as in primary HRS cells of all cHL cases. Forced expression of these factors in cHL-derived cell lines resulted in the activation of cotransfected Ig promoter constructs, underscoring their decisive role in the regulation of Ig transcription. 14 Their important role for B lymphopoiesis and Ig gene transcription was also shown in knock-out experiments where PU.1 is crucial for the development of several hematopoietic lineages 15 and BOB.1/OBF.1 is critical for high titers of secondary Ig isotypes. 16,17 Taking into account that in cHLderived cell lines class-switch recombination is often targeted to IgG4 or IgA, 18 down-regulation of BOB.1/OBF.1 could be the explanation for decreased Ig transcription in many cHL cases. Therefore, it is an unexpected finding that simultaneous cotransfection of Oct2 and BOB.1/OBF.1 expression plasmids in cHL-derived cell lines is unable to reactivate endogenous Ig production. 14 This fact implies the existence of alternative mechanisms of Ig suppression in HRS cells, which are different from genetic mutations and downregulation of transcription factors.It has become clear that loss of gene function in cancer cells is mediated at least as often by epigenetic factors as by gene mutations. 19 Epigenetic silencing in cancer cells generally proceeds through aberrant promoter cytidine guanidine dinucleotide (CpG) methylation, followed by the binding of methyl-binding proteins and the recruitment of transcriptional corepressors, chromatin remodeling proteins, and histone deacetylases. 20,21 Finally, modification of histones, induced by such complexes, results in the formation of a condensed chromatin structure known as a "heterochromatin," which is associated with transcriptionally inactive regions. 22 Epigenetic silencing, in particular, was found to be responsible for down-regulation of numerous t...